Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Andrew D. Dickinson

At a glance: Andrew D. Dickinson is CFO at Gilead Sciences (GILD). Their latest SEC Form 4, filed Nov 17, 2026, reported a sale of $514K. On file: 0 purchase lines ($0) and 14 sale lines ($5.7M).

Disclosed holdings: about $26.4M of GILD stock: 158,096 shares reported on their latest Form 4 (filed Nov 17, 2026), valued at the Nov 19, 2026 close of $167.13. This counts only GILD shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

CFO at Gilead Sciences, Inc. (GILD)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.7M

Andrew D. Dickinson's InsiderPrint

14 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Andrew D. Dickinson: 14 trades, 2025 to 20262025: 0 buys, 3 sales2026: 0 buys, 11 sales

Reading this print: Almost only sells, trading about 13 times a year, typically $415K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (14)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Charles J. ProberDirector · LIF · 100% match
  2. Joseph B. ArmesCEO, President · CSW · 100% match
  3. Gary BowmanCEO · BWMN · 100% match
  4. Paul CunninghamPresident · CDNS · 100% match
  5. Rajesh PankajCTO · IDCC · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 17SEC GILDGilead Sciences, Inc. Sell Plan 3,000158,096 held (−2%) $171.47 $514K -2.5%
Oct 16SEC GILDGilead Sciences, Inc. Sell Plan 3,000161,096 held (−2%) $156.22 $469K +7.0%
Sep 16SEC GILDGilead Sciences, Inc. Sell Plan 3,000164,096 held (−2%) $145.29 $436K +15.0%
Aug 18SEC GILDGilead Sciences, Inc. Sell Plan 3,000165,646 held (−2%) $138.36 $415K +20.8%
Jul 16SEC GILDGilead Sciences, Inc. Sell Plan 3,000168,646 held (−2%) $129.93 $390K +28.6%
Jun 16SEC GILDGilead Sciences, Inc. Sell Plan 3,000171,646 held (−2%) $125.40 $376K +33.3%
May 18SEC GILDGilead Sciences, Inc. Sell Plan 3,000173,191 held (−2%) $132.27 $397K +26.4%
Apr 16SEC GILDGilead Sciences, Inc. Sell Plan 3,000176,191 held (−2%) $140.96 $423K +18.6%
Mar 17SEC GILDGilead Sciences, Inc. Sell Plan 3,000179,191 held (−2%) $144.23 $433K +15.9%
Feb 18SEC GILDGilead Sciences, Inc. Sell Plan 3,000167,779 held (−2%) $154.43 $463K +8.2%
Jan 16SEC GILDGilead Sciences, Inc. Sell Plan 3,000150,503 held (−2%) $124.31 $373K +34.5%
Dec 16SEC GILDGilead Sciences, Inc. Sell Plan 3,000153,503 held (−2%) $122.00 $366K +37.0%
Nov 18SEC GILDGilead Sciences, Inc. Sell Plan 2,500154,555 held (−2%) $125.23 $313K +33.5%
Oct 16SEC GILDGilead Sciences, Inc. Sell Plan 2,500157,055 held (−2%) $118.08 $295K +41.5%
  • Sell

    CFO Andrew D Dickinson sold $514K of GILD at $171.47 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Andrew D Dickinson sold $469K of GILD at $156.22 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Andrew D Dickinson sold $436K of GILD at $145.29 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Andrew D Dickinson sold $415K of GILD at $138.36 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Andrew D Dickinson sold $390K of GILD at $129.93 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Andrew D Dickinson sold $376K of GILD at $125.40 — pre-scheduled 10b5-1 plan sale.

Follow Andrew D. Dickinson

Get one email when Andrew D. Dickinson files a new purchase or sale. Free.

At most one email a day about Andrew D. Dickinson, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.